Evidence map›Paper›PMID 34665924›Full record

ArticleAngewandte Chemie (International ed. in English)2021

A Strategy for Site- and Chemoselective C-H Alkenylation through Osmaelectrooxidative Catalysis.

Isaac Choi, Antonis M Messinis, Xiaoyan Hou, Lutz Ackermann

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Palladium-Catalyzed Electrooxidative Double C-H Arylation.Journal of the American Chemical Society · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Isaac ChoiInstitut für Organische und Biomolekulare Chemie and Wöhler Research Institute for Sustainable Chemistry (WISCh), Georg-August-Universität, Tammanstraße 2, 37077, Göttingen, Germany.ORCID 0000-0002-9207-4845
Antonis M MessinisInstitut für Organische und Biomolekulare Chemie and Wöhler Research Institute for Sustainable Chemistry (WISCh), Georg-August-Universität, Tammanstraße 2, 37077, Göttingen, Germany.ORCID 0000-0002-6168-355X
Xiaoyan HouInstitut für Organische und Biomolekulare Chemie and Wöhler Research Institute for Sustainable Chemistry (WISCh), Georg-August-Universität, Tammanstraße 2, 37077, Göttingen, Germany.
Lutz AckermannInstitut für Organische und Biomolekulare Chemie and Wöhler Research Institute for Sustainable Chemistry (WISCh), Georg-August-Universität, Tammanstraße 2, 37077, Göttingen, Germany.ORCID 0000-0001-7034-8772

Funding

China Sponsorship CouncilDeutsche Forschungsgemeinschaft Gottfried-Wilhelm-Leibniz-PreisEuropean Research CouncilH2020 Marie Skłodowska-Curie Actions 895404Kwanjeong Educational Foundation
6 · The paper itself

Abstract

Herein, we disclose osmaelectrocatalyzed C-H activations that set the stage for electrooxidative alkyne annulations by benzoic acids. The osmium electrocatalysis enables site- and chemoselective electrooxidative C-H activations with unique levels of selectivity. The isolation of unprecedented osmium(0) and osmium(II) intermediates, along with crystallographic characterization and analyses by spectrometric and spectroscopic in operando techniques delineate a synergistic osmium redox catalyst regime. Detailed mechanistic studies revealed a facile C-H cleavage, which allows for an ample substrate scope, providing provide robust and user-friendly access to annulated heterocycles.

Indexed as

C−H activationelectrocatalysiselectrochemistryosmiumselectivity

Identifiers

PMID34665924
PMCPMC9298884
OpenAlexW3207362022

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.